4-[4-[(4R,5S)-4-methyl-2-oxo-1,3-oxazolidin-5-yl]phenyl]-1-N-[(3R)-pyrrolidin-3-yl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide

InChIKey	`MMDRDTANGPSQJU-YRILPIOLSA-N`
Compound Name	4-[4-[(4R,5S)-4-methyl-2-oxo-1,3-oxazolidin-5-yl]phenyl]-1-N-[(3R)-pyrrolidin-3-yl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide
Canonical SMILES	`C[C@H]1NC(=O)O[C@H]1c1ccc(-c2ccc(S(=O)(=O)N[C@@H]3CCNC3)c(S(N)(=O)=O)c2-c2nnn[nH]2)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	10.38
Source	BindingDB;ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
C7C422	blaNDM-1	Klebsiella pneumoniae	Pathogen	PF00753	10.7	IC50	ChEMBL;BindingDB
P52699		Serratia marcescens	Pathogen	PF00753	10.4	IC50	BindingDB
Q2QC95	blaoxa-10	Klebsiella pneumoniae	Pathogen	PF00905	10.2	IC50	BindingDB
Q5GN09	vim-1	Klebsiella pneumoniae	Pathogen	PF00753	10.2	IC50	BindingDB